针对日本脑炎病毒的RNAi疗法:基因标,传递平台和转化障碍
Maneesh Kumar1, Pratima Gupta2, Suman Kumar2
1State VRDL, Department of Microbiology, All India Institute of Medical Sciences, Deoghar, 814152, Jharkhand, India.
Virology
|October 24, 2025
概括
RNA干扰 (RNAi) 通过向保存的基因,为抗击日本脑炎病毒 (JEV) 提供了一个有前途的抗病毒策略. 传递系统的进步提高了疗效,尽管临床翻译需要克服传递效率和免疫反应等挑战.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 日本脑炎病毒 (JEV) 是亚洲病毒性脑炎的主要原因,特别是在儿童中.
- 目前的疫苗和媒介控制对新的JEV基因型和不完整的覆盖有局限性.
- RNA干扰 (RNAi) 是一种针对病毒复制的新型治疗方法.
研究的目的:
- 审查针对JEV的基于RNAi的治疗方法.
- 为了突出保留的病毒基因点RNAi.
- 讨论RNAi传递平台的进步和翻译挑战.
主要方法:
- 对JEV的RNAi当前文献的综述.
- 对保存的JEV基因标 (C,E,NS3,NS5) 的分析.
- 评估新型RNAi传递系统 (脂质纳米粒子,病毒载体).
主要成果:
- 临床前研究表明,在小鼠模型中,病毒RNA抑制率>90%,脑病毒载量降低.
- 保存的JEV基因是跨基因型的有效目标.
- 交付平台表现出更好的稳定性和血脑屏障的透.
结论:
- RNAi是对抗JEV的有效策略,具有有前临床结果的前临床结果.
- 交付创新对于治疗成功至关重要.
- 临床翻译需要解决诸如传递效率,免疫反应和病毒逃逸等挑战.
相关概念视频
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
RNA Interference
27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
Leaky Scanning
5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K


